ADAM12

From WikiMD's Medical Encyclopedia

Revision as of 03:02, 17 March 2025 by Prab (talk | contribs) (CSV import)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

  1. ADAM12

ADAM12, also known as A Disintegrin And Metalloproteinase 12, is a member of the ADAM family of proteins. These proteins are characterized by their disintegrin and metalloproteinase domains, which are involved in a variety of biological processes, including cell adhesion, cell fusion, and proteolysis.

Structure[edit]

ADAM12 is a type I transmembrane protein that consists of several distinct domains:

  • **Pro-domain**: This domain is involved in the regulation of the protein's activity. It is cleaved off to activate the enzyme.
  • **Metalloproteinase domain**: This domain contains the catalytic site responsible for the protein's proteolytic activity.
  • **Disintegrin domain**: This domain is involved in cell-cell and cell-matrix interactions.
  • **Cysteine-rich domain**: This domain may play a role in substrate recognition.
  • **EGF-like domain**: This domain is similar to epidermal growth factor and may be involved in protein-protein interactions.
  • **Transmembrane domain**: This domain anchors the protein in the cell membrane.
  • **Cytoplasmic tail**: This domain is involved in intracellular signaling.

Function[edit]

ADAM12 is involved in several physiological and pathological processes:

  • **Cell adhesion and migration**: ADAM12 can modulate cell adhesion and migration by interacting with integrins and other cell surface proteins.
  • **Proteolysis**: It can cleave various substrates, including growth factors and cytokines, thereby regulating their activity.
  • **Cell signaling**: The cytoplasmic tail of ADAM12 can interact with intracellular signaling molecules, influencing pathways such as the MAPK and PI3K/AKT pathways.
  • **Tissue remodeling**: ADAM12 is involved in tissue remodeling processes, such as those occurring during development and wound healing.

Clinical Significance[edit]

ADAM12 has been implicated in several diseases:

  • **Cancer**: Overexpression of ADAM12 has been observed in various cancers, including breast, prostate, and liver cancer. It may promote tumor progression by enhancing cell migration and invasion.
  • **Fibrosis**: ADAM12 is involved in the development of fibrosis in organs such as the liver and lungs.
  • **Muscular dystrophy**: Mutations in the ADAM12 gene have been associated with certain forms of muscular dystrophy.

Research[edit]

Research on ADAM12 is ongoing to better understand its role in health and disease. Potential therapeutic strategies targeting ADAM12 are being explored, particularly in the context of cancer and fibrotic diseases.

Also see[edit]


Stub icon
   This article is a protein-related stub. You can help WikiMD by expanding it!


Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

W8MD's happy loser(weight)

Tired of being overweight?

Special offer:

Budget GLP-1 weight loss medications

  • Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
  • Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay

✔ Same-week appointments, evenings & weekends

Learn more:

Advertise on WikiMD


WikiMD Medical Encyclopedia

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.